Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

Song, Xuejiao; Gao, Tiantao; Wang, Ningyu; Feng, Qiang; You, Xinyu; Ye, Tinghong; Lei, Qian; Zhu, Yongxia; Xiong, Menghua; Xia, Yong; Yang, Fangfang; Shi, Yaojie; Wei, Yuquan; Zhang, Lidan; Yu, Luoting

doi:10.1038/srep24893

erratumScientific ReportsApr 29, 2016GOLD OA

Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

XSXuejiao Song TGTiantao Gao NWNingyu Wang QFQiang Feng XYXinyu You

Indexed incrossrefdoaj

Abstract

Scientific Reports 6: Article number: 20864; Published online: 12 February 2016; Updated: 29 April 2016 This Article contains typographical errors. In the Results section under subheading ‘Impact of ZLD1039 on breast cancer cell growth’, “Among the cell lines, MCF-7 and ZR-75-1 were the most sensitive to ZLD1039 with IC50 values of 0.

Citation impact

715

total citations

FWCI: 33.77
Percentile: 100%
References: 0

Citations per year

Authors

15

Topics & keywords

Topics

Epigenetics and DNA Methylation96%

Keywords

Breast cancer
Section (typography)
Cancer cell lines
Cancer
Computer science
Computational biology
Cancer research
Oncology

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.